BNP Paribas Financial Markets raised its holdings in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 1,965.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 551,912 shares of the health services provider's stock after acquiring an additional 525,192 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.43% of Select Medical worth $10,404,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also made changes to their positions in the business. Smartleaf Asset Management LLC lifted its holdings in shares of Select Medical by 179.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after purchasing an additional 1,473 shares during the last quarter. Covestor Ltd lifted its holdings in shares of Select Medical by 33.5% in the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock valued at $93,000 after purchasing an additional 1,244 shares during the last quarter. Tidal Investments LLC purchased a new stake in shares of Select Medical in the 3rd quarter valued at about $286,000. Quarry LP lifted its holdings in shares of Select Medical by 963.0% in the 4th quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after purchasing an additional 8,224 shares during the last quarter. Finally, HBK Investments L P purchased a new stake in shares of Select Medical in the 4th quarter valued at about $188,000. 89.48% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the company. Mizuho assumed coverage on Select Medical in a report on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price for the company. Benchmark raised Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a research note on Monday, February 24th. Royal Bank of Canada reduced their price objective on Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research note on Wednesday, May 7th. Finally, StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, Select Medical currently has an average rating of "Moderate Buy" and an average price target of $26.00.
Check Out Our Latest Report on Select Medical
Select Medical Stock Performance
NYSE SEM opened at $14.91 on Monday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The business's 50 day moving average is $16.57 and its two-hundred day moving average is $21.01. Select Medical Holdings Co. has a 12-month low of $14.03 and a 12-month high of $40.98. The stock has a market capitalization of $1.92 billion, a price-to-earnings ratio of 9.04, a PEG ratio of 0.64 and a beta of 1.40.
Select Medical (NYSE:SEM - Get Free Report) last released its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the previous year, the firm posted $0.75 EPS. The business's revenue for the quarter was down 24.4% on a year-over-year basis. Research analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current year.
Select Medical Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be given a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.68%. The ex-dividend date of this dividend is Thursday, May 15th. Select Medical's payout ratio is 18.66%.
Select Medical announced that its board has authorized a share repurchase program on Thursday, May 1st that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the health services provider to buy up to 42.6% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board of directors believes its stock is undervalued.
Insiders Place Their Bets
In other news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the stock in a transaction that occurred on Monday, May 5th. The shares were acquired at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the acquisition, the director now directly owns 65,089 shares in the company, valued at approximately $977,636.78. The trade was a 47.63% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David S. Chernow sold 225,000 shares of the company's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the sale, the chief executive officer now owns 714,516 shares in the company, valued at approximately $12,861,288. This represents a 23.95% decrease in their position. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by insiders.
About Select Medical
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report